stage ii breast cancer
Showing 51 - 75 of 104
Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer Trial in Chicago (eribulin mesylate,
Unknown status
- Estrogen Receptor-negative Breast Cancer
- +10 more
- eribulin mesylate
- +2 more
-
Chicago, IllinoisNorthwestern University
Jun 6, 2019
Sleep Disorder, Stage IA Breast Cancer, Stage IB Breast Cancer Trial in United States (Brief Behavioral Therapy, Telephone-Based
Completed
- Sleep Disorder
- +6 more
- Brief Behavioral Therapy
- +2 more
-
Stanford, California
- +5 more
Jun 3, 2019
Ductal Breast Carcinoma In Situ, Stage IA Breast Cancer, Stage IB Breast Cancer Trial in Los Angeles (Contrast-enhanced Magnetic
Completed
- Ductal Breast Carcinoma In Situ
- +3 more
- Contrast-enhanced Magnetic Resonance Imaging
- +4 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
May 14, 2019
Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Cleveland (trastuzumab, Pertuzumab,
Completed
- Stage II Breast Cancer
- +3 more
- trastuzumab
- +7 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Feb 14, 2019
Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer Trial in Winston-Salem (other, behavioral, procedure)
Completed
- Stage IA Breast Cancer
- +6 more
- educational intervention
- +4 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Jan 23, 2019
HER2/Neu Positive, Stage IA Breast Cancer, Stage IB Breast Cancer Trial in Puerto Rico, United States (drug, other, procedure,
HER2-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer Trial in Omaha (drug, biological, other)
Terminated
- HER2-negative Breast Cancer
- +4 more
- doxorubicin hydrochloride
- +6 more
-
Omaha, NebraskaUNMC Eppley Cancer Center at the University of Nebraska Medical
Dec 10, 2018
HER2-positive Breast Cancer, Male Breast Cancer, Stage II Breast Cancer Trial in Rochester (HER-2/neu peptide vaccine,
Completed
- HER2-positive Breast Cancer
- +5 more
- HER-2/neu peptide vaccine
- laboratory biomarker analysis
-
Rochester, MinnesotaMayo Clinic
Oct 4, 2018
Ductal Carcinoma in Situ, Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in
Completed
- Ductal Carcinoma in Situ
- +7 more
- letrozole
- zoledronic acid
-
Baltimore, MarylandJohns Hopkins University
Aug 14, 2018
Stage II Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer Trial in Columbus (Best Practice, Exercise
Unknown status
- Stage II Breast Cancer
- +6 more
- Best Practice
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 7, 2018
Cardiovascular Complications, Recurrent Breast Cancer, Stage I Breast Cancer Trial in Winston-Salem (drug, other, procedure)
Terminated
- Cardiovascular Complications
- +7 more
- rosuvastatin
- +3 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jul 30, 2018
Estrogen Receptor-positive Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Male Breast Cancer Trial
Terminated
- Estrogen Receptor-positive Breast Cancer
- +6 more
- anastrozole
- +2 more
-
Tucson, ArizonaArizona Cancer Center
Jul 23, 2018
Breast Cancer, Inflammatory Breast Cancer, Stage I Breast Cancer Trial in Cleveland (MUC-1 peptide vaccine, poly ICLC, MUC1
Completed
- Breast Cancer
- +7 more
- MUC-1 peptide vaccine
- +5 more
-
Cleveland, OhioCase Medical Center, University Hospitals Seidman Cancer Center,
Jul 19, 2018
Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer Trial in Winston-Salem (other, behavioral, procedure)
Completed
- Stage I Breast Cancer
- +5 more
- questionnaire administration
- +5 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jul 2, 2018
Cognitive/Functional Effects, Recurrent Breast Cancer, Stage IA Breast Cancer Trial in Winston-Salem (ultrasound imaging,
Completed
- Cognitive/Functional Effects
- +7 more
- ultrasound imaging
- +4 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jul 2, 2018
Anxiety Disorder, Depression, Ductal Breast Carcinoma in Situ Trial in Winston-Salem (yoga therapy, internet-based intervention,
Terminated
- Anxiety Disorder
- +9 more
- yoga therapy
- +2 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Jun 29, 2018
Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer Trial in Seattle
Completed
- Estrogen Receptor-negative Breast Cancer
- +8 more
- doxorubicin hydrochloride
- +13 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Feb 12, 2018
Stage I Breast Cancer, Stage I Cervical Cancer, Stage I Ovarian Cancer Trial in Philadelphia, Reading (Informational
Completed
- Stage I Breast Cancer
- +38 more
- Informational Intervention
-
Philadelphia, Pennsylvania
- +1 more
Feb 20, 2018
Anxiety Disorder, Depression, Ductal Breast Carcinoma in Situ Trial in Seattle (educational intervention, counseling
Completed
- Anxiety Disorder
- +10 more
- educational intervention
- +2 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Feb 6, 2018
Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer Trial in Duarte, Pasadena (acupuncture therapy, questionnaire
Terminated
- Breast Cancer
- +5 more
- acupuncture therapy
- +2 more
-
Duarte, California
- +1 more
Nov 2, 2017
Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer Trial in Tucson (diindolylmethane, )
Completed
- Stage IA Breast Cancer
- +3 more
- diindolylmethane
- placebo
-
Tucson, ArizonaArizona Cancer Center
Oct 31, 2017
HER2-positive Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer Trial in Houston, Shinjuku-ku, Chuo-ku (drug,
Completed
- HER2-positive Breast Cancer
- +2 more
- lapatinib ditosylate
- +5 more
-
Houston, Texas
- +2 more
Aug 9, 2017
Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Stage IA Breast Cancer Trial in Seattle (drug,
Completed
- Estrogen Receptor-positive Breast Cancer
- +8 more
- doxorubicin hydrochloride
- +6 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Aug 30, 2017
Male Breast Cancer, Nausea and Vomiting, Stage I Breast Cancer Trial in Seattle (drug, procedure, other)
Completed
- Male Breast Cancer
- +4 more
- palonosetron hydrochloride
- +8 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Jun 10, 2017